ICC was done on the constructs for two main purposes: i) to confirm the presence of BFCN’s with the staining of Tuj1, FOXG1, and ChAT; and ii) to see if the AD models displayed the two hallmarks of AD, namely amyloid plaques and hyperphosphorylated tau. The gene discussed is MAPT; the disease is Alzheimer disease.